|
Julius pregunto:
A few months <a href=" http://www.crosscarefoodbank.ie/index.php/customer-relationship-management-essay ">becoming a chef essay</a> ** PROSENSA, $7.93, down 67 pct (1:17 p.m. ET) An experimental drug for Duchenne muscular dystrophy fromGlaxoSmithKline and Prosensa failed to meet its goal in alate-stage clinical trial, the companies said on Friday. Thedrug, drisapersen, did not show a statistically significantimprovement in the distance that patients could walk in sixminutes compared to a placebo in the Phase three test. |
|
|
|
